The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan to Test Ivermectin for COVID-19: Prime Minister
May 7, 2020
-
BUSINESS Gilead Files Remdesivir for COVID-19 in Japan
May 4, 2020
-
REGULATORY Japan Likely to Take FDA’s Anticipated EUA as Cue for “Special” Remdesivir OK
May 1, 2020
-
BUSINESS Sanofi Japan to Ensure Drug Supplies, Employees’ Safety at the Same Time in COVID-19 Crisis: Chief
April 30, 2020
-
REGULATORY Japan Might Approve Gilead’s Remdesivir for COVID-19 in May
April 28, 2020
-
BUSINESS Novartis Japan Scraps Sales Offices to Boost Efficiency of Rep Activities
April 27, 2020
-
REGULATORY Japan Moving to Thwart Foreign Takeover of Drug, Medical Devices Makers
April 24, 2020
-
BUSINESS Gene Techno CEO Eyes Lucentis Biosimilar Launch in November 2021, Expects Share of “At Least 30%”
April 23, 2020
-
BUSINESS Japan Heading into Earnings Season amid Coronavirus Woes
April 22, 2020
-
BUSINESS Drug Makers Restricting Nafamostat Supplies as Hopes Grow for Its Repurposing for COVID-19
April 22, 2020
-
COMMENTARY Drug Rep Number Might Have Logged 5,000-Plus Decrease in 1 Year: Jiho Tally
April 22, 2020
-
BUSINESS Sawai Curbing Shipments for 2 More Drugs after Nichi-Iko’s Massive Recalls
April 21, 2020
-
BUSINESS Sumitomo Dainippon Chair Sees No Need for Further Consolidation among Japan Drug Makers
April 21, 2020
-
BUSINESS Some Drug Makers Rejuvenating Workforce by Boosting New Hires after Job Cuts: Jiho Survey
April 20, 2020
-
BUSINESS Big 3 Generic Makers to Discontinue Procaterol Tablets as API Procurement Stalls
April 17, 2020
-
BUSINESS Vibegron Prescription Soars after 14-Day Limit Lifted, Triggering Shipment Curbs
April 16, 2020
-
BUSINESS Gilead Japan to Seek Early Remdesivir Filing If Initial Data Prove Positive: Development Chief
April 16, 2020
-
BUSINESS Fujifilm Starts Boosting Avigan Production for COVID-19
April 16, 2020
-
BUSINESS Ono Curbing Camostat Supplies after Drug Reported as Potential COVID-19 Hopeful
April 15, 2020
-
BUSINESS Gilead Launches PIII Remdesivir Trials for COVID-19 in Japan
April 15, 2020
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…